Corrigendum to “Intestinal, portal, and peripheral profiles of daikenchuto (TU-100)'s active ingredients after oral administration”(Pharmacol Res Perspect., (2015), 3, (e00165), 10.1002/prp2.165);Intestinal, portal, and peripheral profiles of daikenchuto (TU-100)'s active ingredients after oral administration

Pharmacology Research and Perspectives

Volumn 3, Issue 5, 2015, Pages

  Watanabe, Junko ^a   Kaifuchi, Noriko ^a   Kushida, Hirotaka ^a   Matsumoto, Takashi ^a   Fukutake, Miwako ^a   Nishiyama, Mitsue ^a   Yamamoto, Masahiro ^a   Kono, Toru ^b,c  

^a TSUMURA AND CO   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c Sapporo Higashi Tokushukai Hospital   (Japan)

Author keywords

Daikenchuto; gingerol; ginsenosides; luminal concentration; shogaol

Indexed keywords

(6) GINGEROL; DAIKENCHUTO; GINGEROL; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RG 1; HERBACEOUS AGENT; SHOGAOL; TU 100; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COLON CANCER; CROHN DISEASE; DRUG ABSORPTION; DRUG MECHANISM; DRUG MEGADOSE; ELIMINATION HALF-LIFE; ENTEROPATHY; FEMALE; HERBAL MEDICINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ILEOSTOMY; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION; TIME TO MAXIMUM PLASMA CONCENTRATION; ULCERATIVE COLITIS;

EID: 84951823196     PISSN: None     EISSN: 20521707     Source Type: Journal    
DOI: 10.1002/prp2.1206     Document Type: Erratum

References (43)

1. Asami A, Shimada T, Mizuhara Y, Asano T, Takeda S, Aburada T, et al. (2010). Pharmacokinetics of [6]-shogaol, a pungent ingredient of Zingiber officinale Roscoe (Part I). J Nat Med 64: 281–287.
2. Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH (2002). Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull 25: 743–747.
3. Bautista DM, Sigal YM, Milstein AD, Garrison JL, Zorn JA, Tsuruda PR, et al. (2008). Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channels. Nat Neurosci 11: 772–779.
4. Chen H, Lv L, Soroka D, Warin RF, Parks TA, Hu Y, et al. (2012). Metabolism of [6]-shogaol in mice and in cancer cells. Drug Metab Dispos 40: 742–753.
5. Crozier A, Del Rio D, Clifford MN (2010). Bioavailability of dietary flavonoids and phenolic compounds. Mol Aspects Med 31: 446–467.
6. Dong L, Cheng B, Luo Y, Zhang N, Duan H, Jiang M, et al. (2014). Identification of nuclear factor-kappaB inhibitors and beta2 adrenergic receptor agonists in Chinese medicinal preparation Fuzilizhong pills using UPLC with quadrupole time-of-flight MS. Phytochem Anal 25: 113–121.
7. Hasegawa H (2004). Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid. J Pharmacol Sci 95: 153–157.
8. Hollman PC (2014). Unravelling of the health effects of polyphenols is a complex puzzle complicated by metabolism. Arch Biochem Biophys 559: 100–105.
9. Hollman PC, Cassidy A, Comte B, Heinonen M, Richelle M, Richling E, et al. (2011). The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr 141: 989S–1009S.
10. Iturrino J, Camilleri M, Wong BS, Linker Nord SJ, Burton D, Zinsmeister AR (2013). Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation. Aliment Pharmacol Ther 37: 776–785.
11. Iwabu J, Watanabe J, Hirakura K, Ozaki Y, Hanazaki K (2010). Profiling of the compounds absorbed in human plasma and urine after oral administration of a traditional Japanese (Kampo) medicine, daikenchuto. Drug Metab Dispos 38: 2040–2048.
12. Karpagam V, Sathishkumar N, Sathiyamoorthy S, Rasappan P, Shila S, Kim YJ, et al. (2013). Identification of BACE1 inhibitors from Panax ginseng saponins-An Insilco approach. Comput Biol Med 43: 1037–1044.
13. Kim YS, Kim JJ, Cho KH, Jung WS, Moon SK, Park EK, et al. (2008). Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells. J Microbiol Biotechnol 18: 1109–1114.
14. Kono T, Kanematsu T, Kitajima M (2009). Exodus of Kampo, traditional Japanese medicine, from the complementary and alternative medicines: is it time yet? Surgery 146: 837–840.
15. Kono T, Kaneko A, Omiya Y, Ohbuchi K, Ohno N, Yamamoto M (2013). Epithelial transient receptor potential ankyrin 1 (TRPA1)-dependent adrenomedullin upregulates blood flow in rat small intestine. Am J Physiol Gastrointest Liver Physiol 304: G428–G436.
16. Koo JY, Jang Y, Cho H, Lee CH, Jang KH, Chang YH, et al. (2007). Hydroxy-alpha-sanshool activates TRPV1 and TRPA1 in sensory neurons. Eur J Neuorsci 26: 1139–1147.
17. Kubota K, Ohtake N, Ohbuchi K, Mase A, Imamura S, Sudo Y, et al. (2015). Hydroxy-alpha sanshool induces colonic motor activity in rat proximal colon: a possible involvement of KCNK9. Am J Physiol Gastrointest Liver Physiol 308: G579–G590.
18. Landete JM (2012). Updated knowledge about polyphenols: functions, bioavailability, metabolism, and health. Crit Rev Food Sci Nutr 52: 936–948.
19. Lee DS, Kim YS, Ko CN, Cho KH, Bae HS, Lee KS, et al. (2002). Fecal metabolic activities of herbal components to bioactive compounds. Arch Pharmacal Res 25: 165–169.
20. Lu JM, Yao Q, Chen C (2009). Ginseng compounds: an update on their molecular mechanisms and medical applications. Curr Vasc Pharmacol 7: 293–302.
21. Manabe N, Camilleri M, Rao A, Wong BS, Burton D, Busciglio I, et al. (2010). Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans. Am J Physiol Gastrointest Liver Physiol 298: G970–G975.
22. Munekage M, Kitagawa H, Ichikawa K, Watanabe J, Aoki K, Kono T, et al. (2011). Pharmacokinetics of daikenchuto, a traditional Japanese medicine (Kampo) after single oral administration to healthy Japanese volunteers. Drug Metab Dispos 39: 1784–1788.
23. Munekage M, Ichikawa K, Kitagawa H, Ishihara K, Uehara H, Watanabe J, et al. (2013). Population pharmacokinetic analysis of daikenchuto, a traditional Japanese medicine (Kampo) in Japanese and US health volunteers. Drug Metab Dispos 41: 1256–1263.
24. Narita M, Hatano E, Tamaki N, Yamanaka K, Yanagida A, Nagata H, et al. (2009). Dai-kenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver. J Gastroenterol Hepatol 24: 1051–1057.
25. Nievergelt A, Huonker P, Schoop R, Altmann KH, Gertsch J (2010). Identification of serotonin 5-HT1A receptor partial agonists in ginger. Bioorg Med Chem 18: 3345–3351.
26. Nozawa K, Kawabata-Shoda E, Doihara H, Kojima R, Okada H, Mochizuki S, et al. (2009). TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc Natl Acad Sci USA 106: 3408–3413.
27. Ogasawara T, Morine Y, Ikemoto T, Imura S, Fujii M, Soejima Y, et al. (2008). Influence of Dai-kenchu-to (DKT) on human portal blood flow. Hepatogastroenterology 55: 574–577.
28. Okada K, Kawai M, Uesaka K, Kodera Y, Nagano H, Murakami Y, et al. (2013). Effect of Daikenchuto (TJ-100) on postoperative bowel motility and on prevention of paralytic ileus after pancreaticoduodenectomy: a multicenter, randomized, placebo-controlled phase II trial (the JAPAN-PD study). Jpn J Clin Oncol 43: 436–438.
29. Park EK, Choo MK, Han MJ, Kim DH (2004). Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int Arch Allergy Immunol 133: 113–120.
30. Park HY, Choi HD, Eom H, Choi I (2013). Enzymatic modification enhances the protective activity of citrus flavonoids against alcohol-induced liver disease. Food Chem 139: 231–240.
31. Riera CE, Menozzi-Smarrito C, Affolter M, Michlig S, Munari C, Robert F, et al. (2009). Compounds from Sichuan and Melegueta peppers activate, covalently and non-covalently, TRPA1 and TRPV1 channels. Br J Pharmacol 157: 1398–1409.
32. Shen H, Leung WI, Ruan JQ, Li SL, Lei JP, Wang YT, et al. (2013). Biotransformation of ginsenoside Rb1 via the gypenoside pathway by human gut bacteria. Chin Med 8: 22.
33. Shimada M, Morine Y, Nagano H, Hatano E, Kaiho T, Miyazaki M, et al. (2015). Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001). Int J Clin Oncol 20: 95–104.
34. Tachikawa E, Kudo K (2004). Proof of the mysterious efficacy of ginseng: basic and clinical trials: suppression of adrenal medullary function in vitro by ginseng. J Pharmacol Sci 95: 140–144.
35. Terao J (2009). Dietary flavonoids as antioxidants. Forum Nutr 61: 87–94.
36. Tokita Y, Yuzurihara M, Sakaguchi M, Satoh K, Kase Y (2007). The pharmacological effects of Daikenchuto, a traditional herbal medicine, on delayed gastrointestinal transit in rat postoperative ileus. J Pharmacol Sci 104: 303–310.
37. Tokita Y, Yamamoto M, Satoh K, Nishiyama M, Iizuka S, Imamura S, et al. (2011). Possible involvement of the transient receptor potential vanilloid type 1 channel in postoperative adhesive obstruction and its prevention by a Kampo (traditional Japanese) medicine, daikenchuto. J Pharmacol Sci 115: 75–83.
38. Wachtel-Galor S, Benzie IFF (2011). Herbal medicine: an introduction to its history, usage, regulation, current trends, and research needs. in I. F. F. Benzie and S. Wachtel-Galor, eds. Herbal medicine: biomolecular and clinical aspects. Llc, Boca Raton, FL, 2nd edition, Chapter 1.
39. Wakabayashi C, Hasegawa H, Murata J, Saiki I (1997). In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Oncol Res 9: 411–417.
40. Yamamoto M, Miura N, Ohtake N, Amagaya S, Ishige A, Sasaki H, et al. (2000). Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in mice. Gastroenterology 118: 380–389.
41. Yang XD, Yang YY, Ouyang DS, Yang GP (2015). A review of biotransformation and pharmacology of ginsenoside compound K. Fitoterapia 100: 208–20.
42. Yim JS, Kim YS, Moon SK, Cho KH, Bae HS, Kim JJ, et al. (2004). Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora. Biol Pharm Bull 27: 1580–1583.
43. Zhang AL, Changli Xue C, Fong HHS (2011). Integration of Herbal Medicine into Evidence-Based Clinical Practice: Current Status and Issues. in I. F. F. Benzie and S. Wachtel-Galor, eds. Herbal medicine: biomolecular and clinical aspects. Llc, Boca Raton, FL. 2nd edition, chapter 22